Literature DB >> 31881270

Solubility of solid intermediate of pharmaceutical compounds in pure organic solvents using semi-empirical models.

Falamarz Akbari1, Khadijeh Didehban2, Mona Farhang2.   

Abstract

A new semi-theoretical equation is suggested for correlation of solid-liquid solubility data with temperature. The (solid + liquid) equilibrium for Terephthaldialdehyde, 4-Nitro-o-phennylenediamine, 2,4-dihydro- 5-methyl-2-(4-methylphenyl)-3H-pyrazol-3-one (also named 1-(p-tolyl)-3-methyl-5pyrazolone (PTMP)), 2-Amino-5-methylthiazole and 5-chloro-1-methyl-4-nitroimidazole in 18 solvents is correlated with semi-empirical models at temperatures T = 273.15-318.15 K under a pressure of 101.2 kPa. Moreover, a modified Apelblat model, λh model, Wilson model, NRTL model, new flexible equation as Akbari, Dideban and Farhang model (ADF) and for first time the modified Scatchard-Hildebrand equation were utilized to calculate the experiment values. The performance of both ADF and modified Scatchard-Hildebrand equation have been checked by calculating the solubility data with the AARD% of 1.3808% (for 775 data points) and 0.65% (for 100 data points), respectively. The Wilson model is applied to estimate the mixing Gibbs energy, mixing enthalpy, mixing entropy, activity coefficient (ln γ1∞) and reduced excess enthalpy (H1E, ∞) at infinitesimal concentration were calculated.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intermediate; Pharmaceutical; Semi-empirical model; Solid; Solubility

Mesh:

Substances:

Year:  2019        PMID: 31881270     DOI: 10.1016/j.ejps.2019.105209

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  1 in total

1.  Using static method to measure tolmetin solubility at different pressures and temperatures in supercritical carbon dioxide.

Authors:  Mahboubeh Pishnamazi; Samyar Zabihi; Pegah Sarafzadeh; Fatemeh Borousan; Azam Marjani; Rasool Pelalak; Saeed Shirazian
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.